AU2560300A - Acetamido acetonitrile derivatives as inhibitors of cathepsin l and/or cathepsins - Google Patents
Acetamido acetonitrile derivatives as inhibitors of cathepsin l and/or cathepsinsInfo
- Publication number
- AU2560300A AU2560300A AU25603/00A AU2560300A AU2560300A AU 2560300 A AU2560300 A AU 2560300A AU 25603/00 A AU25603/00 A AU 25603/00A AU 2560300 A AU2560300 A AU 2560300A AU 2560300 A AU2560300 A AU 2560300A
- Authority
- AU
- Australia
- Prior art keywords
- cathepsins
- cathepsin
- acetamido
- inhibitors
- acetonitrile derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/24—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton
- C07C255/29—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton containing cyano groups and acylated amino groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/57—Nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pulmonology (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Furan Compounds (AREA)
- Pyrrole Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9903857.2A GB9903857D0 (en) | 1999-02-20 | 1999-02-20 | Chemical compounds |
GB9903857 | 1999-02-20 | ||
GB9916098 | 1999-07-10 | ||
GBGB9916098.8A GB9916098D0 (en) | 1999-07-10 | 1999-07-10 | Chemical compounds |
PCT/GB2000/000532 WO2000049007A1 (en) | 1999-02-20 | 2000-02-16 | Acetamido acetonitrile derivatives as inhibitors of cathepsin l and/or cathepsin s |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2560300A true AU2560300A (en) | 2000-09-04 |
Family
ID=26315158
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU25603/00A Abandoned AU2560300A (en) | 1999-02-20 | 2000-02-16 | Acetamido acetonitrile derivatives as inhibitors of cathepsin l and/or cathepsins |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1155010A1 (en) |
JP (1) | JP2002537293A (en) |
AU (1) | AU2560300A (en) |
WO (1) | WO2000049007A1 (en) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1452522A3 (en) * | 1999-03-15 | 2005-02-09 | Axys Pharmaceuticals, Inc. | Novel compounds and compositions as protease inhibitors |
HUP0200503A3 (en) | 1999-03-15 | 2005-06-28 | Axys Pharmaceuticals Inc South | N-cyanomethyl amides as protease inhibitors and pharmaceutical compositions containing them |
DE60132975T2 (en) * | 2000-01-06 | 2009-02-26 | Merck Frosst Canada Inc., Kirkland | NEW SUBSTANCES AND COMPOUNDS AS PROTEASE INHIBITORS |
GB0003111D0 (en) | 2000-02-10 | 2000-03-29 | Novartis Ag | Organic compounds |
US6812237B2 (en) | 2000-05-15 | 2004-11-02 | Novartis Ag | N-substituted peptidyl nitriles as cysteine cathepsin inhibitors |
EP1283825B1 (en) * | 2000-05-15 | 2005-09-14 | Novartis AG | N-substituted peptidyl nitriles as cysteine cathepsin inhibitors |
AU2002224942A1 (en) * | 2000-12-20 | 2002-07-01 | Syngenta Participations Ag | N-acyl aminoacetonitriles having pesticidal properties |
US7030116B2 (en) | 2000-12-22 | 2006-04-18 | Aventis Pharmaceuticals Inc. | Compounds and compositions as cathepsin inhibitors |
JP2004523506A (en) | 2000-12-22 | 2004-08-05 | アクシス・ファーマシューティカルズ・インコーポレイテッド | Novel compounds and compositions as cathepsin inhibitors |
AU2002254099B2 (en) | 2001-03-02 | 2006-07-06 | Axys Pharmaceuticals, Inc. | Cathepsin cysteine protease inhibitors |
US6982263B2 (en) | 2001-06-08 | 2006-01-03 | Boehringer Ingelheim Pharmaceuticals, Inc. | Nitriles useful as reversible inhibitors of cysteine proteases |
PL369312A1 (en) | 2001-09-14 | 2005-04-18 | Aventis Pharmaceuticals Inc. | Novel compounds and compositions as cathepsin inhibitors |
CN1324018C (en) | 2001-11-14 | 2007-07-04 | 安万特药物公司 | Oligopeptides and compositions containing them as cathepsin S inhibitors |
BRPI0308208B8 (en) | 2002-03-05 | 2021-05-25 | Axys Pharm Inc | cathepsin cysteine protease inhibitor compounds and pharmaceutical compositions comprising the same |
US6878706B1 (en) | 2002-04-05 | 2005-04-12 | Boehringer Ingelheim Pharmaceuticals Inc. | Cyanamides useful as reversible inhibitors of cysteine proteases |
ATE388946T1 (en) * | 2002-04-05 | 2008-03-15 | Boehringer Ingelheim Pharma | CYANAMIDE AS A REVERSIBLE INHIBITOR OF CYSTEIN PROTEASES |
KR100962972B1 (en) | 2002-07-26 | 2010-06-09 | 주식회사유한양행 | 1-phenylpiperidin-3-one derivatives and processes for the preparation thereof |
CA2495939A1 (en) | 2002-09-04 | 2004-03-18 | Merck Frosst Canada & Co./Merck Frosst Canada & Cie | Cathepsin cysteine protease inhibitors |
US20060046979A1 (en) | 2002-09-24 | 2006-03-02 | Foster Carolyn A | Organic compounds |
US7326719B2 (en) | 2003-03-13 | 2008-02-05 | Boehringer Ingelheim Pharmaceuticals, Inc. | Cathepsin S inhibitors |
US7465745B2 (en) | 2003-03-13 | 2008-12-16 | Boehringer Ingelheim Pharmaceuticals, Inc. | Cathepsin S inhibitors |
WO2004089395A2 (en) * | 2003-04-01 | 2004-10-21 | Aventis Pharmaceuticals Inc. | Use of an inhibitor of cathepsin-s or -b to treat or prevent chronic obstructive pulmonary disease |
US7297714B2 (en) * | 2003-10-21 | 2007-11-20 | Irm Llc | Inhibitors of cathepsin S |
US7423176B2 (en) * | 2004-04-13 | 2008-09-09 | Cephalon, Inc. | Bicyclic aromatic sulfinyl derivatives |
BRPI0515470A (en) * | 2004-09-17 | 2008-07-22 | Schering Ag | processes and intermediates for preparation of cysteine protease inhibitors |
JP2008545720A (en) * | 2005-06-02 | 2008-12-18 | メルク フロスト カナダ リミテツド | Fluoroalkylamine derivatives as cathepsin inhibitors |
US20080227863A1 (en) * | 2005-07-25 | 2008-09-18 | Novartis Ag | Organic Compounds |
JP5587790B2 (en) | 2008-01-09 | 2014-09-10 | アミュラ セラピューティクス リミティド | Compound |
KR20160131126A (en) | 2008-06-20 | 2016-11-15 | 노파르티스 아게 | Paediatric compositions for treating multiple sclerosis |
EP2198879A1 (en) | 2008-12-11 | 2010-06-23 | Institut Curie | CD74 modulator agent for regulating dendritic cell migration and device for studying the motility capacity of a cell |
EP2920158A1 (en) | 2012-11-14 | 2015-09-23 | F. Hoffmann-La Roche AG | Novel acetamide derivatives as trp channel antagonists |
JP6556700B2 (en) | 2013-09-13 | 2019-08-07 | ピットニー ファーマシューティカル ピーティーワイ リミテッド | Anticancer agent containing aminoacetonitrile compound as active ingredient |
CN115466225A (en) * | 2022-08-16 | 2022-12-13 | 中国科学院上海药物研究所 | Amide compound, preparation method, pharmaceutical composition and application thereof |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2846127A1 (en) * | 1978-10-23 | 1980-04-30 | Basf Ag | 1,2,4-TRIAZOL-1-YL COMPOUNDS, THEIR PRODUCTION AND USE AS FUNGICIDES |
FR2446812A1 (en) * | 1979-01-16 | 1980-08-14 | Produits Ind Cie Fse | PHENOXY- AND THIOPHENOXYNITRILES AND THEIR APPLICATIONS AS HERBICIDES |
US4567267A (en) * | 1981-06-15 | 1986-01-28 | American Home Products Corporation | α-Phenyl-2-(aza)benzothiazolylthioglycolic acids and derivatives thereof |
ES2043625T3 (en) * | 1986-08-29 | 1994-01-01 | Shell Int Research | ARILOXICARBOXYLIC ACID DERIVATIVES, THEIR PREPARATION AND USE. |
US5055451A (en) * | 1986-12-22 | 1991-10-08 | Syntex Inc. | Aryloxy and arylacyloxy methyl ketones as thiol protease inhibitors |
JPH03218347A (en) * | 1989-11-10 | 1991-09-25 | Nippon Soda Co Ltd | Carboxylic acid amide derivative and its preparation |
JPH05286937A (en) * | 1992-04-10 | 1993-11-02 | Mitsubishi Petrochem Co Ltd | Substituted pyridyloxycarboxylic acid amide derivative and agricultural bactericide containing the same |
JPH06211766A (en) * | 1993-01-18 | 1994-08-02 | Mitsubishi Petrochem Co Ltd | Alkoxycarboxylic acid amide derivative and agricultural fungicide containing the derivative |
JP2848232B2 (en) * | 1993-02-19 | 1999-01-20 | 武田薬品工業株式会社 | Aldehyde derivatives |
US5486623A (en) * | 1993-12-08 | 1996-01-23 | Prototek, Inc. | Cysteine protease inhibitors containing heterocyclic leaving groups |
KR100511339B1 (en) * | 1996-10-31 | 2005-08-31 | 구미아이 가가쿠 고교 가부시키가이샤 | Pyrimidinyloxyalkanoic amide derivatives and fungicides for agricultural and horticultural use |
US5942640A (en) * | 1998-04-20 | 1999-08-24 | American Cyanamid Company | Process for the manufacture of N-(1-cyanoalkyl)-2-phenoxypropionamide derivatives |
-
2000
- 2000-02-16 AU AU25603/00A patent/AU2560300A/en not_active Abandoned
- 2000-02-16 EP EP00903848A patent/EP1155010A1/en not_active Withdrawn
- 2000-02-16 WO PCT/GB2000/000532 patent/WO2000049007A1/en active Search and Examination
- 2000-02-16 JP JP2000599747A patent/JP2002537293A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP1155010A1 (en) | 2001-11-21 |
WO2000049007A8 (en) | 2001-03-15 |
WO2000049007A1 (en) | 2000-08-24 |
JP2002537293A (en) | 2002-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2560300A (en) | Acetamido acetonitrile derivatives as inhibitors of cathepsin l and/or cathepsins | |
AU2002363005A1 (en) | Derivatives of uk-2a | |
AU4180900A (en) | Novel amide derivatives as inhibitors of matrix metalloproteinases, tnf-alpha, and aggrecanase | |
AU2560000A (en) | Di- and tripeptide nitrile derivatives as inhibitors of cathepsin l and cathepsin | |
AU6465400A (en) | Inhibition of action potentials | |
GB9911417D0 (en) | Furanone derivatives as inhibitors of cathepsin s | |
AU2001269046A1 (en) | Use of therapeutic benzamide derivatives | |
AU5619400A (en) | Statine-derived tetrapeptide inhibitors of beta-secretase | |
AU2001260418A1 (en) | Use of ergothioneine and/or its derivatives as anti-pollution agent | |
AU2002211370A1 (en) | Inhibition of tgf-beta and uses thereof | |
AU2002217866A1 (en) | Geldanamycin derivatives useful for the treatment of cancer | |
AU4989400A (en) | Stabilization of isothiazolone | |
AU2002214868A1 (en) | Therapeutic oligonucleotides of reduced toxicity | |
AU1646201A (en) | Pharmaceutical agent for the treatment of cachexia and/or cardiogenic shock | |
AU8005100A (en) | Inhibitors of neuraminidases | |
AU2001274022A1 (en) | Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments | |
AU2003238175A1 (en) | Treatment of serious infections and septic shock | |
AU3971700A (en) | Cyclobutene-3,4-dione derivatives as inhibitors of phosphodiesterase | |
AU2001291233A1 (en) | Polymorphs of pioglitazone hydrochloride and their use as antidiabetics | |
AU4021700A (en) | Methods of use of beta1-integrin inhibitors | |
AU2001272490A1 (en) | Use of galiella lactone | |
AU1392601A (en) | Prevention and treatment of biomaterial-associated infections | |
AU3397301A (en) | Treatment of hookworm infection | |
AU2002215766A1 (en) | Gamma-ketoacid dipeptide derivatives as inhibitors of caspase-3 | |
AU3757200A (en) | Treatment of pulmonary hypertension |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |